Chemoinformaics analysis of (+)-alpha-Cadinene
Molecular Weight | 204.357 | nRot | 1 |
Heavy Atom Molecular Weight | 180.165 | nRig | 11 |
Exact Molecular Weight | 204.188 | nRing | 2 |
Solubility: LogS | -5.173 | nHRing | 0 |
Solubility: LogP | 6.135 | No. of Aliphatic Rings | 2 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
Atoms Count | 39 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 0 |
nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
nHA | 0 | APOL | 41.053 |
nHD | 0 | BPOL | 24.077 |
QED | 0.548 |
Synth | 3.925 |
Natural Product Likeliness | 2.981 |
NR-PPAR-gamma | 0.003 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.016 |
Pgp-sub | 0.018 |
HIA | 0.004 |
CACO-2 | -4.385 |
MDCK | 0.000016 |
BBB | 0.138 |
PPB | 0.946361 |
VDSS | 5.373 |
FU | 0.0305243 |
CYP1A2-inh | 0.869 |
CYP1A2-sub | 0.453 |
CYP2c19-inh | 0.581 |
CYP2c19-sub | 0.861 |
CYP2c9-inh | 0.734 |
CYP2c9-sub | 0.261 |
CYP2d6-inh | 0.054 |
CYP2d6-sub | 0.221 |
CYP3a4-inh | 0.522 |
CYP3a4-sub | 0.349 |
CL | 14.18 |
T12 | 0.118 |
hERG | 0.069 |
Ames | 0.026 |
ROA | 0.051 |
SkinSen | 0.37 |
Carcinogencity | 0.426 |
EI | 0.845 |
Respiratory | 0.348 |
NR-Aromatase | 0.003 |
Antiviral | Yes |
Prediction | 0.905931 |